BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 26513397)

  • 1. DWI Lesion Patterns Predict Outcome in Stroke Patients with Thrombolysis.
    Liu D; Scalzo F; Starkman S; Rao NM; Hinman JD; Kim D; Ali LK; Saver JL; Noorian AR; Ng K; Liang C; Sheth SA; Yoo B; Liu X; Liebeskind DS;
    Cerebrovasc Dis; 2015; 40(5-6):279-285. PubMed ID: 26513397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
    Kim DH; Lee DS; Nah HW; Cha JK
    BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early infarct growth predicts long-term clinical outcome after thrombolysis.
    Cho KH; Kwon SU; Lee DH; Shim W; Choi C; Kim SJ; Suh DC; Kim JS; Kang DW
    J Neurol Sci; 2012 May; 316(1-2):99-103. PubMed ID: 22326365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and tissue response to intravenous thrombolysis in tandem internal carotid artery/middle cerebral artery occlusion: an MRI study.
    Thomalla G; Kruetzelmann A; Siemonsen S; Gerloff C; Rosenkranz M; Röther J; Fiehler J
    Stroke; 2008 May; 39(5):1616-8. PubMed ID: 18323483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Diffusion Lesion Volume Above 70 mL Preclude Favorable Outcome Despite Post-Thrombolysis Recanalization?
    Tisserand M; Turc G; Charron S; Legrand L; Edjlali M; Seners P; Roca P; Lion S; Naggara O; Mas JL; Méder JF; Baron JC; Oppenheim C
    Stroke; 2016 Apr; 47(4):1005-11. PubMed ID: 26979862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distance to thrombus on MR angiography predicts outcome of middle cerebral artery occlusion treated with IV thrombolysis.
    Gawlitza M; Friedrich B; Quäschling U; Schob S; Schaudinn A; Hobohm C; Hoffmann KT; Lobsien D
    Neuroradiology; 2015 Oct; 57(10):991-7. PubMed ID: 26162293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of clinical outcome in patients with acute perforating artery infarction.
    Yang L; Cao W; Wu F; Ling Y; Cheng X; Dong Q
    J Neurol Sci; 2016 Jun; 365():108-13. PubMed ID: 27206885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
    Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
    Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
    J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between neurological worsening and lesion patterns in patients with acute middle cerebral artery stenosis.
    Tamura A; Yamamoto Y; Nagakane Y; Takezawa H; Koizumi T; Makita N; Makino M
    Cerebrovasc Dis; 2013; 35(3):268-75. PubMed ID: 23548833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of deep white matter lesions on diffusion-weighted imaging is a negative predictor of early dramatic improvement after intravenous tissue plasminogen activator thrombolysis.
    Kawano H; Hirano T; Inatomi Y; Terasaki T; Yonehara T; Uchino M
    Cerebrovasc Dis; 2010 Aug; 30(3):230-6. PubMed ID: 20606424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous thrombolysis for patients with reverse magnetic resonance angiography and diffusion-weighted imaging mismatch: SAMURAI and NCVC rt-PA Registries.
    Sakamoto Y; Koga M; Kimura K; Nagatsuka K; Okuda S; Kario K; Hasegawa Y; Okada Y; Yamagami H; Furui E; Nakagawara J; Shiokawa Y; Okata T; Kobayashi J; Tanaka E; Minematsu K; Toyoda K
    Eur J Neurol; 2014 Mar; 21(3):419-26. PubMed ID: 24261412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
    Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.
    Deguchi I; Takeda H; Furuya D; Dembo T; Nagoya H; Kato Y; Ito Y; Fukuoka T; Maruyama H; Tanahashi N
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):108-13. PubMed ID: 20851627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis targeting MRI defined tissue at risk in minor stroke.
    Kruetzelmann A; Siemonsen S; Gerloff C; Rosenkranz M; Röther J; Fiehler J; Thomalla G
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1156-8. PubMed ID: 19762906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.